The U.S. Food and Drug Administration has approved Incyte's eczema cream for children aged between 2 and 11 years, the ...

Incyte Announces Additional FDA Approval of Opzelura® (Ruxolitinib) Cream in Children Ages 2-11 with Atopic Dermatitis ...

The U.S. Food and Drug Administration has approved Incyte's eczema treatment for children aged between 2 and 11 years, the company said on Thursday. It was previously approved for individuals aged 12 ...

If you experience chronic dry, itchy and red skin, you may be one of the millions of Americans with eczema. The National Eczema Association reports that an estimated 10% of the world population ...

Red, itchy, and scaly skin from atopic dermatitis and eczema can be uncomfortable, confusing, and all too familiar. These chronic (meaning they can last a long time) inflammatory conditions can appear ...

US drug developer Nektar Therapeutics saw its shares rise 9% to $55.66 following release of new data from the ongoing REZOLVE ...

Investing.com -- Nektar Therapeutics (NASDAQ:NKTR) stock jumped 7% Thursday after the company announced positive results from its REZOLVE-AD Phase 2b study of rezpegaldesleukin for moderate-to-severe ...

That morning, Nektar published new data from a phase 2b study of rezpegaldesleukin, which targets moderate to severe atopic dermatitis, a skin disorder. Image source: . The healthcare company said ...

Experts break down the most important facts about atopic dermatitis on the hands, including risk factors, treatments, and tips for soothing relief. Atopic dermatitis (AD), the most common form of ...

When you have atopic dermatitis, a form of eczema, it can be easy to dismiss symptoms like dry, itchy skin as normal for you. But even if you’re able to live with these symptoms, doing so can create a ...

First FDA-approved medication for atopic dermatitis (eczema), plaque psoriasis, and seborrheic dermatitis to win prominent “Breakthrough ...